Abstract

Mesalamine 100-mg/mL Suspension Enema

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2022 - Volume 26, Number 2

Page(s): 144

Download in electronic PDF format for $75
  • Mesalamine 100-mg/mL Suspension Enema Page 1

Note: Electronic version includes supplemental material.

Abstract

A formulation for preparing Mesalamine 100-mg/mL Suspension Enema. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • mesalamine
  • ulcerative colitis
  • anti-inflammatory agent
  • inflammation
  • suspension enema

Related Categories

  • FORMULATIONS
  • GASTROENTEROLOGY
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2022
Pg. 144
Mesalamine 100-mg/mL Suspension Enema
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Jul/Aug 2011
Pg. 338
Hydrocortisone 100-mg/60-mL Retention Enema
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 424
Rebamipide Rectal Enema Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 427-430
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Author(s): Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jan/Feb 1998
Pg. 53
Progesterone Enema 100- and 200-mg/mL
Author(s): Allen Loyd V Jr
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Nov/Dec 2019
Pg. 490
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2003
Pg. 389-393
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Author(s): Alexander Kenneth S, Thyangarajapuram N
Nov/Dec 2016
Pg. 495-500
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 53
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 66-75
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
May/Jun 2018
Pg. 239
Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 416
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 340
Methylprednisolone 4-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 185
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 1999
Pg. 225
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop
Author(s): Allen Loyd V Jr